Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR-4375 in Combination With Other Antitumor Therapies in Advanced Solid Tumors
NCT07298772Phase 2Recruiting
- Sponsor
- Suzhou Suncadia Biopharmaceutical
- Start
- Jan 2026
- Primary completion
- Jan 2027
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of SHR-4375 in solid tumor, sponsored by Suzhou Suncadia Biopharmaceutical. Started Jan 2026; status: recruiting.
02
Drugs
SHR-4375
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07298772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07298772.